A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain
- Disease/Condition
- Pain
- Drug/Device/Intervention
- Voltaren Gel 1% (diclofenac sodium) (US only)
- Study type
- Interventional
- Intervention type
- drug
- Primary sponsor
- HALEON
- Location
- Marrero,San Antonio,Bydgoszcz,Chojnice,Katowice,Malbork,Ostróda,Łódź, Poland,United States of America
- Phase
- Phase 4
- Start date
- Apr 25, 2024
- End date
- Nov 15, 2024
- Enrollment
- 195 participants
Change from Baseline in the Average Minutes of Moderate and Vigorous Physical Activity (MVPA) at Week 1,Change from Baseline in the Average Minutes of MVPA at Week 2,Change from Baseline in the Average Minutes of MVPA at Week 3
The purpose of this study is to investigate how topical diclofenac use can improve functional
 mobility and physical activity primarily, as well as other quality-of-life (QoL) parameters
 such as sleep, mood, and engagement in daily activities in participants with knee OA.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06379893
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06379893 through Pure Global AI's free database. This Phase 4 trial is sponsored by HALEON and is currently Recruiting. The study focuses on Pain. Target enrollment is 195 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.